icon-    folder.gif   Conference Reports for NATAP  
 
  (APASL) 24th Conference of the Asian Pacific
Association for the Study of the Liver
12-15 March, 2014
Brisbane, Australia
Back grey_arrow_rt.gif
 
 
 
Characterization of Resistance in HCV Genotype 1b-Infected Japanese and Western Patients Treated With an Interferon- and Ribavirin-Free Regimen of Ombitasvir and Paritaprevir/Ritonavir
 
 
  Reported by Jules Levin
APASL 2015
24th Conference of the Asian Pacific Association for the Study of the Liver (APASL), 12-15 March 2015, Istanbul, Turkey
 
Tami Pilot-Mati as1, Gretja Schnell1, Rakesh Tripathi1, Thomas Reisch1, Jill Beyer1, Preethi Krishnan1, Liangjun Lu1, Teresa Ng1, Lino Rodrigues-Jr1, Carolyn Setze1, Xinyan Zhang1, Coleen Hall1, Regis A Vilchez1, Christine Collins1, Christophe Hezode2, Kazuaki Chayama3, Hiromitsu Kumada4 1AbbVie Inc., North Chicago, Illinois, United States; 2Department of Hepatology and Gastroenterology, H™pital Henri Mondor, AP-HP, Universitˇ Paris-Est, INSERM U955, Crˇteil, France; 3Department of Gastroenterology and Metabolism, Hiroshima University, Hiroshima, Japan; 4Department of Hepatology, Toranomon Hospital, Tokyo, Japan

APASL1.gif

APASL2.gif

APASL3.gif

APASL4.gif

APASL5.gif

APASL6.gif

APASL7.gif

APASL8.gif

APASL9.gif

APASL10.gif

APASL11.gif

APASL12.gif

APASL13.gif

references.gif